KK

Kranthi Kumar Sunnepaneni

Active Director Director DIN 09662233
DIN 09662233 First appointment Jul 2022 Primary industry Non-Profit Organizations
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Kranthi Kumar Sunnepaneni

Data last updated:

Kranthi Kumar Sunnepaneni is a Director at Sri Lakshmi Advanced Medical Sciences Private Limited (since 2022). The company operates in Non-Profit Organizations.

DIN 09662233
Primary Designation Director
Industry Non-Profit Organizations
First Appointment 05 Jul 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Jul 20222022Active

Directorship timeline

Open interactive timeline →
Sri Lakshmi Advanced Medical Sciences Private Limited
Premium access

Shareholding and investment profile for Kranthi Kumar Sunnepaneni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kranthi Kumar Sunnepaneni

Kranthi Kumar Sunnepaneni currently holds 1 directorship: Sri Lakshmi Advanced Medical Sciences Private Limited (Director, since 05 Jul 2022).

Kranthi Kumar Sunnepaneni was first appointed on 05 Jul 2022 as Director at Sri Lakshmi Advanced Medical Sciences Private Limited.

The current boards of Kranthi Kumar Sunnepaneni's companies include Nandaluru Sravan Kumar Reddy (Sri Lakshmi Advanced Medical Sciences Private Limited), Vamsidhar Akkula Gari (Sri Lakshmi Advanced Medical Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available